Nav: Home

An itch to scratch: NCATS, NIDCR scientists identify potential approach to chronic problem

July 12, 2019

Chronic itch goes beyond being just a simple annoyance; it can greatly affect a person's quality of life. While scientists have some clues to its causes, effective therapies have been elusive.

Now, using a technique called quantitative high-throughput screening to sort through more than 86,000 compounds at the same time, researchers at NCATS and the National Institute of Dental and Craniofacial Research (NIDCR) report a new strategy that may eventually help alleviate chronic itch. They've shown that blocking a receptor, or docking station, found on the surface of both mouse and human spinal cord neurons could be key.

Several years ago, Mark Hoon, Ph.D., and his colleagues at NIDCR found a receptor, Npr1, on mouse spinal cord neurons for a protein associated with itch. The protein fit into Npr1 like a key into a lock, helping turn on the itch sensation. Npr1 appeared to be a potential target for drugs to halt itch.

Hoon contacted NCATS scientist James Inglese, Ph.D., and his team for help in identifying compounds that could block Npr1 activity. The researchers developed a series of assays, or tests, and used robots to screen compounds in human cells, finding approximately 1,400 molecules worth examining more closely. They then developed additional assays to narrow the list to 15 compounds. They showed a subset of these compounds could halt both human and mouse versions of the receptor from working. A follow-up study in mice showed that blocking the receptor reduced scratching.

Next, the scientists will examine more candidate compounds and determine how they block Npr1. They hope the findings will help them choose which compounds to study further and chemically modify as potential anti-itch drugs. Hoon, Inglese and their colleagues reported the results online July 10 in Science Translational Medicine.

"This is a proof-of-concept study and an important application of what NCATS does," Inglese said. "We wanted to show that by pharmacologically blocking the target receptor, the approach could be successful in finding a drug to treat chronic itch. Because it can take a long time to develop an ideal compound, the rationale behind the approach needs to be well vetted."
-end-


NIH/National Center for Advancing Translational Sciences (NCATS)

Related Chronic Itch Articles:

An itch to scratch: NCATS, NIDCR scientists identify potential approach to chronic problem
While scientists have some clues to the causes of troubling chronic itch, effective therapies have been elusive.
Seeking better detection for chronic malaria
In people with chronic malaria, certain metabolic systems in the blood change to support a long-term host-parasite relationship, a finding that is key to eventually developing better detection, treatment and eradication of the disease, according to research published today in the Journal of Clinical Investigation Insight.
Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.
Using light to stop itch
Itch is easily one of the most annoying sensations. For chronic skin diseases like eczema, it's a major symptom.
How the brain tells you to scratch that itch
It's a maddening cycle that has affected us all: it starts with an itch that triggers scratching, but scratching only makes the itchiness worse.
The Center for the Study of Itch reviews what causes chronic itching and scratching
Relentless itch is a feature of many skin disorders, such as eczema and psoriasis, but the cause of this itch -- and what drives us to scratch -- is somewhat mysterious.
New approach to treating chronic itch
Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.
Molecular switch triggers itch
A new study of male mice published in JNeurosci uncovers two distinct pathways through which a single molecule can cause both itchy and painful skin.
Flipping the switch on itch
Researchers have pinpointed a particular neuropeptide associated with transmitting itch signals in mice with atopic dermatitis.
At odds: Less sensory neurons induce stronger sensations of itch
The irritating itchiness that affects people as they age and their skin becomes drier may be caused by the loss of Merkel cells, a new study in mice suggests.

Related Chronic Itch Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...